User: Guest

  



DOMAIN EXPERT ENGAGEMENTS

Number of executives repeatedly engaged by snail & email outreach*

POOL + OUTREACH

4293

Interactions with Platform & by Email *

INTERACTIONS

773

Unique # Participated *

PARTICIPANTS

129

Responses Validated *

VALIDATIONS

37

* Platform engagements are dynamic. Stats are published quarterly.


  •  CODE

  •  PAGES

  •  DATE

  •  PRICE

    $

  •  DATA EXHIBITS

    125


TABLE OF CONTENTS


   Pages :    | $

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   Increasing Diabetes Prevalence – A Major Growth Propeller.....II-1
Diabetes – Taking Toll in Developing Countries.....II-1
1$100
   Insulin Therapy for Diabetes Management.....II-2
Insulin Delivery Systems – A Quick Market Primer.....II-2
1$100
   Insulin Pump Therapy: Convenient Alternate to Insulin Injection.....II-3
United States – The Largest Global Market for Insulin Pumps (External).....II-3
Rosy Future Ahead for Insulin Pens.....II-3
1$100
   Select Brands of Disposable Insulin Pens by Manufacturer.....II-4
Select Brands of Reusable Insulin Pens by Manufacturer.....II-4
Innovations in Insulin Delivery – An Overview.....II-4
Select Next-Generation Insulin Delivery Techniques and Devices.....II-4
Pulmonary Insulin Delivery via Inhalers.....II-4
1$100
   Early Jitters Make Pharma Majors Abandon Inhaled Insulin Research.....II-5
Pulmonary Insulin Delivery Research Still Remains Unabated.....II-5
1$100
   Transdermal Delivery of Insulin via Patches.....II-6
Transmucosal Insulin Delivery via Mouth Spray.....II-6
1$100
   Nasal Delivery of Insulin via Nasal Mucosa.....II-7
Hydrogels for Insulin Delivery.....II-7
Oral Insulin Delivery.....II-7
1$100
   Artificial Pancreas Technology – A Promising Approach for Diabetes Treatment.....II-8
Competitive Landscape.....II-8
Insulin Syringes.....II-8
1$100
   Insulin Pumps.....II-9
Insulin Pens.....II-9
1$100
   Pre-Filled Syringes: Gaining Diabetics Attention.....II-10
Insulin Pumps Market: Tough Ground for New Entrants.....II-10
Innovative Features Spruce Up the Market for Insulin Pumps.....II-10
2$125
   Combination Products: The Latest Trend in the Insulin Pump Market.....II-12
Implantable Insulin Pumps: Emerging Technology in the Insulin Pump Market.....II-12
Expiry of Warranty Provides New Opportunities to Insulin Pump Makers.....II-12
1$100
   Insulin Pump Market Issues.....II-13
Insulin Pump Training Not Receiving Adequate Attention.....II-13
Complicated Insulin Pump Software Makes Pump Use Difficult for the Aged.....II-13
1$100
   Diabetes - A Fatal Disease.....II-14
Risk Factors for Diabetes.....II-14
Types of Diabetes.....II-14
Type I Diabetes: Insulin-Dependent Diabetes Mellitus (IDDM).....II-14
1$100
   Type II Diabetes: Non Insulin-Dependent Diabetes Mellitus (NIDDM).....II-15
Long Term Complications of Diabetes.....II-15
1$100
   Pancreas: The Main Source of Insulin in Human Body.....II-16
Types of Insulin & Administration.....II-16
1$100
   Oral Administration.....II-17
Goal of Insulin Therapy.....II-17
Insulin Delivery Systems – An Overview.....II-17
Insulin Syringes.....II-17
1$100
   Insulin Needles.....II-18
Insulin Pens.....II-18
1$100
   Advantages of Insulin Pens.....II-19
Disadvantages of Insulin Pens.....II-19
External Insulin Pumps.....II-19
Insulin Pump Components.....II-19
1$100
   How Does an Insulin Pump Work?.....II-20
Insulin Pump Delivery Rates.....II-20
Advantages of Insulin Pumps.....II-20
More Accurate and Consistent.....II-20
Adjusting Time Zones While Traveling.....II-20
1$100
   Enhances Blood Sugar Control in Pediatric Patients.....II-21
Improves Quality of Life.....II-21
Disadvantages of Insulin Pumps.....II-21
High Cost.....II-21
High Involvement.....II-21
Diabetic Ketoacidosis Risk.....II-21
Glucose Testing at Regular Intervals.....II-21
1$100
   Regular Rotation of Infusion Set.....II-22
Carrying Back-up Kit.....II-22
Regular Refilling of Pump.....II-22
Insulin Jet Injectors.....II-22
Pen Injectors.....II-22
1$100
   Nanotechnology Victoria, Monash University Develop SAW Generated Mechanism, for Insulin
  Delivery.....II-23
Medtronic Emphasizes Cutting-Edge Features of a Closed-Loop Diabetes Management System,
  Currently Under Development.....II-23
Toray Industries and Hoshi University Discover a New Approach for Insulin Delivery Via
  Nasal Spray.....II-23
1$100
   A New Study Demonstrates Superior Benefits of Novo Nordisk's Next Generation FlexPen
  over KwikPen and SoloStar.....II-24
Phosphagenics to Commence Phase II Clinical Trials of Transdermal Insulin Delivery
  System.....II-24
Oramed Pharmaceuticals Begins Phase Ia Trials of Insulin Suppository.....II-24
Debiotech and STMicroelectronics Unveil First Prototype of a Disposable Insulin
  Nanopump.....II-24
1$100
   Braunschweig University Scholar Devises Wristwatch Insulin Pump.....II-251$100
   Novo Nordisk Introduces Preloaded Pen.....II-26
BD Medical Unveils BD AutoShield Pen Needle.....II-26
Novo Nordisk Introduces Flexpen.....II-26
Polymedicure Unveils Insulin syringes.....II-26
Johnson & Johnson Medical India to Unveil Insulin Pumps.....II-26
Generex Rolls Out Oral Insulin Spray.....II-26
1$100
   Eli Lilly Launches KwikPen.....II-27
Smith Medical Launches Cozmo in China.....II-27
Medtronic Unveils Arabic Language Insulin Pump.....II-27
Medtronic Launches New Diabetes Monitoring System.....II-27
1$100
   Eli Lilly to Unveil New Insulin Pen, Memoir.....II-281$100
   JDRF Enters into Partnership with Animas.....II-29
Medtronic Acquires Certain Assets from PreciSense.....II-29
MannKind Inks Agreement to Acquire Pfizer’s German Insulin Facility.....II-29
Owen Mumford Inks Deal with Sanofi-Aventis.....II-29
1$100
   Medingo Obtains FDA Approval for Marketing Insulin Micropump.....II-30
Insulet Wins CE Mark Approval for OmniPod® Insulin Management System.....II-30
Sanofi-aventis Receives FDA Approval for Apidra® SoloSTAR®.....II-30
Novo Nordisk Receives FDA Approval for NovoLog® Labeling Change.....II-30
Patton Medical Devices, Unomedical Enter into Partnership Agreement.....II-30
1$100
   Sanofi-aventis Wins Canadian and EU Approval for ClikSTAR® Insulin Pen.....II-31
DexCom and Animas Amend Insulin Pump Joint Development Deal.....II-31
Medingo Secures FDA Approval for Solo MicroPump Insulin Delivery System.....II-31
Qualitest Pharmaceuticals Recalls Accusure Insulin Syringes.....II-31
Novartis Completes Acquisition of Nektar’s Pulmonary Business.....II-31
1$100
   Smiths Medical Acquires Zhejiang Zheda Medical Instrument.....II-32
ICBS Acquires Vectoris Pharma.....II-32
Sagent Pharma Acquires Rights to ChaSyr, a Multi-Chamber Syringe.....II-32
Novo Nordisk Hands Over Inhaled Insulin Patents to Aradigm.....II-32
Eli Lilly and Alkermes Terminate Inhaled Insulin Development Deal.....II-32
1$100
   Novo-Nordisk Drops Development Plan of Inhaled Insulin.....II-33
Generex, Dongsung Pharm Enter Agreement for Generex Oral-lyn.....II-33
Novo Nordisk Gains FDA Clearance for NovoLog®.....II-33
Novo Nordisk to Construct Insulin Plant in China.....II-33
Generex Biotechnology Enters into Distribution Agreement with SciGen.....II-33
1$100
   Rexam and Eli Lilly to Expand Manufacturing Base for Insulin Pens.....II-34
Merrion to Develop and Market Novo Nordisk’s Insulin Analogues.....II-34
Smiths Medical to Cease Insulin Pumps Sale, Exist Diabetes Business.....II-34
Covidien Recalls Mislabelled Syringes.....II-34
1$100
   Animas Recalls Insulin Pumps with Faulty Battery Cap.....II-35
NationsHealth Acquires Diabetes Care & Education.....II-35
Insulet Inks Agreement with DexCom.....II-35
Insulet Partners with Flextronics.....II-35
Debiotech Allies with STMicroelectronics.....II-35
1$100
   SpectRx Divests Insulin Pump Business.....II-361$100
   Animas Corporation (USA).....II-37
Antares Pharma, Inc. (USA).....II-37
1$100
   Becton, Dickinson and Company (USA).....II-38
Eli Lilly and Company (USA).....II-38
1$100
   F. Hoffmann-La Roche, Ltd. (Switzerland).....II-39
Disetronic Medical Systems, Inc. (USA).....II-39
1$100
   Generex Biotechnology Corp. (Canada).....II-40
Insulet Corp. (USA).....II-40
Medical Plastic Devices Inc. (Canada).....II-40
1$100
   Medtronic Inc. (USA).....II-41
Novo Nordisk A/S (Denmark).....II-41
1$100
   Patton Medical Devices, LP (USA).....II-42
Sanofi-Aventis (France).....II-42
Smiths Medical MD, Inc. (USA).....II-42
1$100
   Ypsomed AG (Switzerland).....II-431$100
   Insulin Syringes:.....II-44
Table 1: World Recent Past, Current & Future Analysis for Insulin Syringes Market by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).....II-44
1$350
   Table 2: World Historic Review for Insulin Syringes Market by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).....II-451$350
   Table 3: World 13-year Perspective for Insulin Syringes Market by Geographic Region - Percentage Breakdown of Value Sales for US, Europe and Rest of World Markets for Years 2003, 2009 & 2015 (includes corresponding Graph/Chart).....II-461$350
   Insulin Pumps (External):.....II-47
Table 4: World Recent Past, Current & Future Analysis for Insulin Pumps (External) Market by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).....II-47
1$350
   Table 5: World Historic Review for Insulin Pumps (External) Market by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).....II-481$350
   Table 6: World 13-year Perspective for Insulin Pumps (External) Market by Geographic Region - Percentage Breakdown of Value Sales for US, Europe and Rest of World Markets for Years 2003, 2009 & 2015 (includes corresponding Graph/Chart).....II-491$350
   Insulin Pens:.....II-50
Table 7: US and Europe Recent Past, Current & Future Analysis for Insulin Pens Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).....II-50
1$350
   Table 8: US and Europe Historic Review for Insulin Pens Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).....II-511$350
   A. Market Analysis.....III-1
Diabetes – A Cause of Concern.....III-1
Table 9: Diabetes Prevalence by Diabetes Type in Millions in the US (2008) (includes corresponding Graph/Chart).....III-1
Surging Diabetic Population Keeps Demand Ticking for Insulin Delivery
  Systems.....III-1
1$200
   External Insulin Pumps: A Key Mechanism for Insulin Delivery.....III-2
Insulin Pens Gaining Immense Prominence.....III-2
Jet Injectors: The Costliest Insulin Delivery System.....III-2
1$75
   Competitive Analysis by Insulin Delivery System.....III-3
Becton Dickinson – The Insulin Syringes Market Leader.....III-3
Table 10: US Insulin Syringes Market (2007): Percentage Share Breakdown by Leading Companies - Becton Dickinson, Kendall, and Others (includes corresponding Graph/Chart).....III-3
Medtronic – The Insulin Pumps Major.....III-3
Table 11: US Insulin Pumps Market (2008): Percentage Share Breakdown of Leading insulin Pump Manufacturers - Medtronic, Animas and Others Comparison of Major Insulin Pump Systems Based on Select Parameters (includes corresponding Graph/Chart).....III-3
1$200
   Product Introductions.....III-41$75
   Strategic Corporate Developments.....III-55$225
   Major Players.....III-104$175
   B. Market Analytics.....III-14
Table 12: US Recent Past, Current & Future Analysis for Insulin Delivery Systems - Insulin Syringes, Insulin Pens, and Insulin Pumps (External) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).....III-14
1$200
   Table 13: US Historic Review for Insulin Delivery Systems - Insulin Syringes, Insulin Pens, and Insulin Pumps (External) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).....III-151$200
   Table 14: US 13-year Perspective for Insulin Delivery Systems - Percentage Breakdown of Value Sales for Insulin Syringes, Insulin Pens, and Insulin Pumps (External) Markets for Years 2003, 2009 & 2015 (includes corresponding Graph/Chart).....III-161$200
   A. Market Analysis.....III-17
European Preference for Insulin Pens Overshadows the Rest of the World
  Demand.....III-17
Insulin Pump Therapy Gaining Favor Among Europeans.....III-17
1$75
   Strategic Corporate Developments.....III-181$75
   Major Players.....III-192$125
   B. Market Analytics.....III-21
Table 15: Europe Recent Past, Current & Future Analysis for Insulin Delivery Systems - Insulin Syringes, Insulin Pens, and Insulin Pumps (External) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).....III-21
1$200
   Table 16: Europe Historic Review for Insulin Delivery Systems - Insulin Syringes, Insulin Pens and Insulin Pumps (External) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).....III-221$200
   Table 17: Europe 13-year Perspective for Insulin Delivery Systems - Percentage Breakdown of Value Sales for Insulin Syringes, Insulin Pens, and Insulin Pumps (External) Markets for Years 2003, 2009 & 2015 (includes corresponding Graph/Chart).....III-231$200
   A. Market Analysis.....III-24
Product Introductions.....III-24
1$75
   Strategic Corporate Developments.....III-251$75
   Major Players.....III-262$125
   B. Market Analytics.....III-28
Table 18: Rest of World Recent Past, Current & Future Analysis for Insulin Delivery Systems - Insulin Syringes and Insulin Pumps (External) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).....III-28
1$200
   Table 19: Rest of World Historic Review for Insulin Delivery Systems - Insulin Syringes and Insulin Pumps (External) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).....III-291$200
   Table 20: Rest of World 13-year Perspective for Insulin Delivery Systems - Percentage Breakdown of Value Sales for Insulin Syringes and Insulin Pumps (External) Markets for Years 2003, 2009 & 2015 (includes corresponding Graph/Chart).....III-301$200
    
 
 


Sales queries: Sales@StrategyR.com
Research queries: Info411@StrategyR.com